Circulation, Vol 69, 1048-1057, Copyright © 1984 by American Heart Association
H Gewirtz, SL Gross, DO Williams and AS Most
This study tested the hypothesis that intrinsic negative inotropic effects
of a drug used to induce coronary vasodilation distal to a severe coronary
arterial stenosis may influence the extent of redistribution of transmural
flow and its metabolic consequences. To test this hypothesis, studies were
conducted in eight closed-chest, sedated swine with severe (82% reduction
in luminal diameter) coronary arterial stenoses. Measurement of hemodynamic
parameters, regional myocardial blood flow (microsphere technique), lactate
metabolism, and oxygen consumption were made (1) under control conditions,
(2) after 10 min of intracoronary infusion of a vasodilator distal to the
stenosis, and (3) under repeat control conditions. Each animal received
both intracoronary adenosine (400 micrograms/min) and nifedipine (50
micrograms/min). The order of drug infusion was chosen at random and a
control period separated administration of each. In response to nifedipine
there was no significant change in the group mean (+/- SD) value of
endocardial flow (1.21 +/- 0.34 to 1.29 +/- 0.61 ml/min X g-1) distal to
the stenosis. In contrast, epicardial flow increased in comparison with
control in response to nifedipine (1.30 +/- 0.58 to 1.79 +/- 0.74 ml/min X
g-1; p less than .05). Regional myocardial oxygen consumption (MVO2)
declined in comparison with control in response to nifedipine (14.0 +/- 4.2
to 11.1 +/- 5.0 ml/min X 100 g-1; p less than .05). Regional lactate
extraction did not change in comparison with control during infusion of
nifedipine (18.2 +/- 22.4 vs 11.7 +/- 16.8). In response to adenosine,
endocardial blood flow distal to the stenosis declined in comparison with
control (1.25 +/- 0.53 to 1.07 +/- 0.38 ml/min X g-1; p less than .05),
while epicardial flow increased (1.31 +/- 0.55 to 2.26 +/- 0.59 ml/min X
g-1; p less than .01). Regional MVO2 also tended to decline in comparison
with control in response to adenosine (13.4 +/- 4.9 to 11.7 +/- 2.9 ml/min
X 100 g- 1) and was significantly (p less than .05) reduced in comparison
with postintervention control (14.6 +/- 4.2 ml/min X 100 g-1). In contrast
to nifedipine, adenosine caused a significant decline in regional lactate
extraction in comparison with control (12.7 +/- 23.2% to -40.6 +/- 55.0%; p
less than .01). Thus, administration of nifedipine, a negative inotropic
agent, resulted in (1) a decline in regional MVO2, (2) increased epicardial
blood flow with variable effects on endocardial flow distal to the
stenosis, and (3) no evidence of de novo or worsening ischemia, even in
animals in which endocardial flow decreased.(ABSTRACT TRUNCATED AT 400
WORDS)
ARTICLES
Contrasting effects of nifedipine and adenosine on regional myocardial flow distribution and metabolism distal to a severe coronary arterial stenosis: observations in sedated, closed-chest, domestic swine
This article has been cited by other articles:
![]() |
G. Holmvang, S. Fry, H. A. Skopicki, S. A. Abraham, N. M. Alpert, A. J. Fischman, M. H. Picard, and H. Gewirtz Relation Between Coronary "Steal" and Contractile Function at Rest in Collateral-Dependent Myocardium of Humans With Ischemic Heart Disease Circulation, May 18, 1999; 99(19): 2510 - 2516. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Skopicki, S. A. Abraham, M. H. Picard, N. M. Alpert, A. J. Fischman, and H. Gewirtz Effects of Dobutamine at Maximally Tolerated Dose on Myocardial Blood Flow in Humans With Ischemic Heart Disease Circulation, November 18, 1997; 96(10): 3346 - 3352. [Abstract] [Full Text] |
||||
![]() |
H. A. Skopicki, S. A. Abraham, N. J. Weissman, A. K. Mukerjee, N. M. Alpert, A. J. Fischman, M. H. Picard, and H. Gewirtz Factors Influencing Regional Myocardial Contractile Response to Inotropic Stimulation: Analysis in Humans With Stable Ischemic Heart Disease Circulation, August 15, 1996; 94(4): 643 - 650. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |